World leaders, civil society and global health researchers will convene at the United Nations General Assembly for arguably the most important meeting on antimicrobial resistance (AMR) this decade.
There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can help researchers identify new antimicrobials.
The contrasting realities of antimicrobial resistance between high-income countries and low- and middle-income countries demands international co-operation to effectively fight superbugs.
Antimicrobial resistance is an epidemic that kills close to 5 million people annually. The solutions are complex and must take into account the needs of the poor.
From the frontline battle against antibiotic resistance in Nigeria, to the techniques being used to find new antibiotics. Listen to The Conversation Weekly podcast.
Sacha Pidot, The Peter Doherty Institute for Infection and Immunity
Scientists are racing to discover new antibiotics that can defeat these drug-resistant superbugs. So how is the newly developed antibiotic clovibactin different?
Up to 20% of Australians admitted in hospital say they have a penicillin allergy. But not everyone who thinks they’re allergic to penicillin actually is.
Antibiotics have been around for less than a century. But as resistant bacteria become increasingly difficult to treat, we risk a greater number of deaths from infections.